Laura E. Archer

机构：The Royal Wolverhampton NHS Trust, Wolverhampton Hospital

发表论文 41 篇 · 总被引 2870 次 · h-index 19

代表论文

• Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206 (2008 · Journal of Clinical Oncology · 被引 907)
• Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206 (2010 · Journal of Clinical Oncology · 被引 791)
• Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104 (2010 · Journal of Clinical Oncology · 被引 130)
• Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer (2009 · Journal of Clinical Oncology · 被引 113)
• Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102) (2012 · Journal of the National Comprehensive Cancer Network · 被引 107)
• Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809 (2011 · European Journal of Cancer · 被引 102)